The consolidation of other immunotherapies and the rise of messenger RNA platforms have boosted scientists’ optimism. However, they point out that there won’t be a universal vaccine for cancer, but rather many highly-personalized ones
Scientists explore the potential of a technique that enabled the rapid development of the first Covid-19 vaccines and which holds immense potential in combating other diseases like cancer, the flu, HIV and autoimmune conditions